PHARMASCIENCE INC. LAUNCHES PMS-FLUTICASONE HFA 250mcg FOR THE TREATMENT OF STEROID-RESPONSIVE BRONCHIAL ASTHMA IN ADULTS AND CHILDREN

Montreal, January 26, 2021  – Pharmascience Inc. is proud to bring to market a new product pms-FLUTICASONE HFA 250mcg (fluticasone propionate inhalation aerosol) for the treatment of the prophylactic management of steroid-responsive bronchial asthma in adults and children 12 months of age and above. Pms-FLUTICASONE HFA 250mcg .

Pharmascience Inc. is one of only two companies launching a generic maintenance treatment for asthma, and the only company offering an inhaler device as the reference brand for a smooth patient transition.

“With the launch of pms-FLUTICASONE HFA 250mcg, we are broadening our product offering in the complex respiratory therapeutic area. Now patients with asthma have a cost-effective solution. As a proudly Canadian company, we are proud to serve Canadians in this very critical time” says Al Moghaddam, Vice President and General Manager of Pharmascience Canada.

 

ABOUT PHARMASCIENCE INC.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2020, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. Also, in 2020, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers.

FLOVENT is a trademark owned by or licensed to the GSK group of companies.

For product information, please contact Pharmascience’s Medical Information Department at 1-888-550-6060.